GDP
VRTX icon

Great Diamond Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Great Diamond Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$669K Sell
1,346
-58
-4% -$25.7K 0.11% 146
2026
Q1 		$627K Sell
1,404
-12
-0.8% -$5.6K 0.12% 143
2025
Q4 		$642K Buy
1,416
+44
+3% +$19K 0.12% 141
2025
Q3 		$537K Sell
1,372
-404
-23% -$169K 0.1% 151
2025
Q2 		$791K Buy
1,776
+423
+31% +$195K 0.17% 126
2025
Q1 		$656K Buy
1,353
+338
+33% +$158K 0.18% 100
2024
Q4 		$409K Sell
1,015
-12
-1% -$5.56K 0.11% 123
2024
Q3 		$478K Sell
1,027
-682
-40% -$328K 0.12% 119
2024
Q2 		$801K Sell
1,709
-34
-2% -$14.8K 0.19% 102
2024
Q1 		$729K Sell
1,743
-16
-0.9% -$6.76K 0.17% 112
2023
Q4 		$716K Buy
1,759
+21
+1% +$7.76K 0.18% 114
2023
Q3 		$604K Buy
1,738
+1
+0.1% +$350 0.16% 119
2023
Q2 		$611K Buy
1,737
+139
+9% +$46.8K 0.16% 118
2023
Q1 		$503K Sell
1,598
-203
-11% -$60.9K 0.15% 125
2022
Q4 		$520K Sell
1,801
-116
-6% -$35.4K 0.16% 119
2022
Q3 		$555K Sell
1,917
-83
-4% -$23.9K 0.19% 107
2022
Q2 		$563K Sell
2,000
-483
-19% -$129K 0.19% 104
2022
Q1 		$647K Sell
2,483
-153
-6% -$36.3K 0.18% 104
2021
Q4 		$578K Sell
2,636
-38
-1% -$7.39K 0.15% 119
2021
Q3 		$485K Buy
+2,674
New +$522K 0.13% 123
2020
Q1 		– Sell
-34
Closed -$7K – 590
2019
Q4 		$7K Buy
+34
New +$6.88K ﹤0.01% 584

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Great Diamond Partners's VRTX Position: Q2 2026 in Review

Great Diamond Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 4.1% in Q2 2026, selling an estimated $25.7K and leaving 1,346 shares worth $669K. The position accounts for 0.11% of the portfolio, ranked #146.

Great Diamond Partners first reported a position in VRTX in Q4 2019 and has held it in 21 quarters since. The position peaked at $801K in Q2 2024. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Great Diamond Partners held 1,346 shares of Vertex Pharmaceuticals worth $669K as of Q2 2026.
  • Great Diamond Partners sold 58 Vertex Pharmaceuticals shares in Q2 2026, an estimated $25.7K.
  • Vertex Pharmaceuticals made up 0.11% of Great Diamond Partners's portfolio in Q2 2026, its #146 holding.
  • Great Diamond Partners first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 21 quarters since.
  • Great Diamond Partners's Vertex Pharmaceuticals position peaked at $801K in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.